Advertisement
Becton, Dickinson and Company

Becton, Dickinson and Company (BDX) Stock Overview

Explore Becton, Dickinson and Company’s financial performance, market position, analyst ratings, and future outlook.

BDXNYSE
HealthcareMedical - Instruments & Supplies
$152.04
$2.05(1.37%)
U.S. Market opens in 9h 47m
Advertisement

Becton, Dickinson and Company (BDX)

Meyka AI Score

Z

Key Financials

Market Cap55.1B
P/E Ratio37.47
EPS (TTM)$5.73
ROE0.05%
Fundamental Analysis

AI Price Forecasts

1 Month$156.25
3 Months$137.73
1 Year Target$157.39

BDX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Becton, Dickinson and Company (BDX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 53.62, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $157.39.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 37.47 and a market capitalization of 55.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
1.31%
5-Day Change
2.07%
1-Month Change
1.69%
3-Month Change
-8.16%
6-Month Change
2.37%
Year-to-Date (YTD) Change
-0.40%
1-Year Change
12.05%
3-Year Change
-23.14%
5-Year Change
-18.59%
All-Time (Max) Change
557.27%

Contact Information

201 847 6800
1 Becton Drive, Franklin Lakes, NJ, 07417-1880

Company Facts

70,000 Employees
IPO DateFeb 21, 1973
CountryUS
Actively Trading

Frequently Asked Questions